Spatial Optimization to Improve COVID-19 Vaccine Allocation
Goodson, J.; Scroggins, S.; Afroze, T.; Shacham, E.
Show abstract
Early distribution of COVID-19 vaccines was largely driven by population size and did not account for COVID-19 prevalence nor location characteristics. In this study, we applied an optimization framework to identify distribution strategies that would have lowered COVID-19 related morbidity and mortality. Optimized vaccine allocation would have decreased case incidence by 8% with 5,926 fewer COVID-19 cases, 106 fewer deaths, and 4.5 million dollars in healthcare cost saved during the first half of 2021. As COVID-19 variants continue to be identified, and the likelihood of future pandemics remains high, application of resource optimization should be a priority for policy makers.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use 94%
- Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response 93%
- Projecting maximum potential demand for nirsevimab to protect eligible US infants and young children against respiratory syncytial virus in the 2024/2025 season 93%
Similar papers in this journal
- The Impact of Vaccination to Control COVID-19 Burden in the United States: A Simulation Modeling Approach 97%
- Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States 93%
- Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost 93%
Similar papers in this journal
- The Balancing Role of Distribution Speed against Varying Efficacy Levels of COVID-19 Vaccines under Variants 93%
- Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilities 93%
- COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact 93%
Similar papers in this journal
- The Joint Impact of COVID-19 Vaccination and Non-Pharmaceutical Interventions on Infections, Hospitalizations, and Mortality: An Agent-Based Simulation 97%
- Identifying silent COVID-19 infections among children is critical for controlling the pandemic 93%
- Estimation of COVID-19 cases prevented by vaccination in California 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.